US President Donald Trump today initiated a series of steps to lower the cost of prescription drugs in the county.
Without naming anyone, Trump also slammed countries that are asking US companies to lower the price of American drugs.
"You can look at some of the countries, their medicine is a tiny fraction what the medicine costs in the USA. It's unfair and it's ridiculous and it's not going to happen any longer. It's time to end the global freeloading once and for all," Trump said amidst applause from the audience in the Rose Garden of the White House.
Trump has directed US Trade Representative Bob Lighthizer to make fixing this injustice a top priority with every trading partner.
"We have great power over the trading partners. You're seeing that already. America will not be cheated any longer, and especially will not be cheated by foreign countries. The American people deserve a healthcare system that takes care of them, not one that taxes and takes advantage of our patients and our consumers and our citizens. These reforms are just the beginning," Trump said.
In the coming weeks, Trump said that his administration would work with the Congress to pass legislation that will save Americans even more money at the pharmacy.
"For that, we need the help of Congress and we think it will be forthcoming," he said.
Trump said that he has instructed his Health Secretary to begin moving forward on reforms that will bring soaring drug prices back down to Earth.
"Our plan takes steps to derail the gravy train for special interests by ending Obamacare's twisted incentives that actually encourage higher drug prices," Trump said.
The US is not going to reward companies that constantly raise prices, which, in the past, has been the case, he said.
"Our plan will end the dishonest double dealing that allows the middleman to pocket rebates and discounts that should be passed on to consumers and patients. Our plan bans the pharmacist gag rule, which punishes pharmacists for telling patients how to save money," the President said.
"We're going to take on one of the biggest obstacles to affordable medicine: the tangled web of special interests. Not too many are sitting here today, but they used to be here all the time. Trump alleged that the drug lobby is making an absolute fortune at the expense of American consumers.
"No industry spends more money on lobbying than the pharmaceutical health products industry. Last year, these companies spent nearly USD 280 million on lobbyists. That's more than tobacco, oil and defence contractors combined," he said.
Health insurance companies and other providers spent another USD 200 million to protect the status quo and to keep prices artificially high. And they've been very successful, doing it for many, many years, he said.
Everyone involved in the broken system - the drug makers, insurance companies, distributors, pharmacy benefit managers and many others contribute to the problem, Trump said.
"The government has also been part of the problem because previous leaders turned a blind eye to this incredible abuse. But, under this administration, we are putting American patients first," Trump added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
